Brigham and Women’s, AI company get $2.5M grant to improve early cognitive decline detection via EHRs

Boston-based Brigham and Women’s Hospital and Melax Tech, a company specializing in natural language processing, have received a $2.5 million National Institutes of Health grant to develop a clinical decision-support tool for early detection of cognitive decline.

Advertisement

The two-year collaboration will develop algorithms to identify patients with early cognitive decline via EHRs and design a clinical decision-support system to provide personalized care recommendations.

“This study is a critical step in our mission to improve the lives of those affected by Alzheimer’s disease and related dementia,” said lead researcher Li Zhou, PhD, of Brigham and Women’s Hospital, in a Feb. 16 new release. “Using deep-learning algorithms and electronic health records can revolutionize how we approach early detection and intervention.”

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Innovation

Advertisement

Comments are closed.